Search research articles
Contact Us
Filters
Showing results (291-300 of 423) with videos related to
Page
of 43
Sort By:
The Journal of Clinical Psychiatry
|
February 8, 2014
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder
Robert L Findling, Raymond Mankoski, Karen Timko, et al.
Child and Adolescent Psychiatry and Mental Health
|
March 21, 2009
The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial
Robert L Findling, Maria E Pagano, Nora K McNamara, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 29, 2010
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study
Atilla Turgay, Lawrence Ginsberg, Elias Sarkis, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
October 17, 2021
Suicide Risk Screening in Pediatric Outpatient Neurodevelopmental Disabilities Clinics
Suzanne Rybczynski, Taylor C Ryan, Holly C Wilcox, et al.
Journal of Clinical Psychopharmacology
|
July 21, 2006
Postpartum depression: a randomized trial of sertraline versus nortriptyline
Katherine L Wisner, Barbara H Hanusa, James M Perel, et al.
Psychopharmacology Bulletin
|
June 7, 2021
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 2, 2005
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder
Robert L Findling, Gianluca Nucci, Antoni A Piergies, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 29, 2018
Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression
Heather M Joseph, Cristan Farmer, Heidi Kipp, et al.
Journal of Psychiatric Research
|
October 16, 2007
Screening for bipolar disorder in a county jail at the time of criminal arrest
David E Kemp, Robert M A Hirschfeld, Stephen J Ganocy, et al.
The Lancet. Digital Health
|
December 18, 2020
A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial
Scott H Kollins, Denton J DeLoss, Elena Cañadas, et al.
Page
of 43
Search research articles
Search
Showing results (291-300 of 423) with videos related to
Sort By:
Page
of 43
The Journal of Clinical Psychiatry
|
February 8, 2014
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder
Robert L Findling, Raymond Mankoski, Karen Timko, et al.
Child and Adolescent Psychiatry and Mental Health
|
March 21, 2009
The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial
Robert L Findling, Maria E Pagano, Nora K McNamara, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 29, 2010
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study
Atilla Turgay, Lawrence Ginsberg, Elias Sarkis, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
October 17, 2021
Suicide Risk Screening in Pediatric Outpatient Neurodevelopmental Disabilities Clinics
Suzanne Rybczynski, Taylor C Ryan, Holly C Wilcox, et al.
Journal of Clinical Psychopharmacology
|
July 21, 2006
Postpartum depression: a randomized trial of sertraline versus nortriptyline
Katherine L Wisner, Barbara H Hanusa, James M Perel, et al.
Psychopharmacology Bulletin
|
June 7, 2021
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 2, 2005
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder
Robert L Findling, Gianluca Nucci, Antoni A Piergies, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 29, 2018
Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression
Heather M Joseph, Cristan Farmer, Heidi Kipp, et al.
Journal of Psychiatric Research
|
October 16, 2007
Screening for bipolar disorder in a county jail at the time of criminal arrest
David E Kemp, Robert M A Hirschfeld, Stephen J Ganocy, et al.
The Lancet. Digital Health
|
December 18, 2020
A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial
Scott H Kollins, Denton J DeLoss, Elena Cañadas, et al.
Page
of 43